Latest News and Press Releases

Company announcement – No. 3 / 2022 Zealand Pharma announces directed issue and private placement corresponding to approx. 6.6 % of existing share capital NOT FOR RELEASE, PUBLICATION OR...

Company announcement – No. 2 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, May 31, 2022 – Zealand Pharma A/S...

PRESS RELEASE – NO. 1 / 2022 Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes Association Scientific Sessions, Including Initial Clinical Data on GLP-1/GLP-2 Dual...

Company announcement – No. 23 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022 Copenhagen, DK and Boston, MA, May 25, 2022 –...

Company announcement – No. 24 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, May 25, 2022 – Zealand Pharma A/S...

Company announcement – No. 22 / 2022 Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatric Patients with Congenital Hyperinsulinism (CHI)   Dasiglucagon met the...

Company announcement – No. 21 / 2022 Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device Deal includes $10 million USD upfront payment to...

Company announcement – No. 20/ 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED] Copenhagen, DK and Boston, MA, May 12, 2022 –...

Company announcement – No. 19 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, May 12, 2022 – Zealand Pharma...

Company announcement – No. 17 / 2022 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 Copenhagen, DK and Boston, MA, May 10 2022 – Zealand Pharma A/S (“Zealand”)...